Choisissez votre région

Sélectionnez la région qui correspond le mieux à votre emplacement ou à vos préférences.

Choisissez la langue du site

Ce paramètre contrôle la langue de l'interface utilisateur, y compris les boutons, les menus et tout le texte du site. Sélectionnez votre langue préférée pour une meilleure expérience de navigation.

Choisissez les langues des offres d'emploi

Sélectionnez les langues des offres d'emploi que vous souhaitez voir. Ce paramètre détermine quelles annonces d'emploi vous seront affichées.

KU Leuven

Postdoctoral researcher to develop antisense therapies for familial Alzheimer’s

2024-11-29 (Europe/Brussels)
Enregistrer le travail

A propos de l'employeur

KU Leuven is an autonomous university. It was founded in 1425. It was born of and has grown within the Catholic tradition.

Visitez la page de l'employeur

The Laboratory for the Research of Neurodegenerative Diseases headed by prof. Bart De Strooper in collaboration with the Laboratory for Therapeutic and Diagnostic Antibodies headed by Prof. Maarten Dewilde, is looking for a motivated postdoctoral scientist to join our multidisciplinary project on gene therapy for Alzheimer’s Disease.
The Laboratory for the Research of Neurodegenerative Diseases is a vibrant environment where key issues related to Alzheimer’s disease are tackled and The laboratory of Therapeutic and Diagnostic Antibodies focusses on the generation and characterization of monoclonal antibodies (Mabs), antibody derivatives, nanobodies and diabodies for application as either therapeutics, diagnostics or research tools.

Responsibilities

This work is focused on the specific targeting of clinical mutations that cause dominant inherited Alzheimer’s disease using a unique antisense strategy (ASO). We will couple those ASO to our proprietary blood-brain shuttles to improve brain exposure, improve administration via intravenous instead of intrathecal routes, and decrease toxicity associated with ASO treatment. 
The candidate will be involved in both the generation and the testing of the ASO constructs and will follow the clinical candidates on their journey from preclinical to clinical application.      
Additional information may be found in the following selected references:              
  • De Strooper, B. & Karran, E. New precision medicine avenues to the prevention of Alzheimer's disease from insights into the structure and function of gamma-secretases. EMBO J 43, 887-903 (2024).
  • Rue, L. et al. Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics. Pharmaceutics 15 (2023).

Profile

The successful candidate:
  • Should hold a PhD degree in neuroscience, biology, chemistry, engineering or a related field
  • Should be creative, enthusiastic, critically thinking, and motivated
  • Ready to work against stringent deadlines
  • Enjoys teamwork and has excellent oral and written communication skills in English.
Appreciated
  • Experience working with laboratory mice (FELASA B)
  • Project management and effective communication skills
  • Knowledge of the literature on neurodegenerative disorders
  • Good understanding of antisense oligonucleotide therapies
  • Interested in brain delivery of drugs
  • Good publication record

Offer

  • An exceptional strong scientific environment
  • Possibility to supervise students and technicians and develop an independent research profile
  • Access to state-of-the-art infrastructure
  • A stimulating, diverse international world-class research environment
  • Animal models, expertise in neurodegenerative disorders
  • Financial support is available for at least 2 years (renewable one year contract). However, the successful candidate is encouraged to obtain a personal fellowship (Marie-Curie, HFSP, EMBO, or National funding organizations).
  • Start date: as soon as possible - the position is available immediately

More information

Find out more about the De Strooper lab via this link
Find out more about the Dewilde via this link
Interested in a virtual visit? Take a look inside our lab here

Interested?

Motivated candidates with a strong interest in neurodegeneration and with a strong commitment to basic research are invited to apply. Please complete the online application procedure and include a CV, a list of publications, a summary of past research and the contact information of 2 to 3 referees. The best-ranked candidates will be invited for an interview.
For additional information concerning this position, please contact Bart De Strooper (Bart.Destrooper@kuleuven.be) or Maarten Dewilde (maarten.dewilde@kuleuven.be)

KU Leuven strives for an inclusive, respectful and socially safe environment. We embrace diversity among individuals and groups as an asset. Open dialogue and differences in perspective are essential for an ambitious research and educational environment. In our commitment to equal opportunity, we recognize the consequences of historical inequalities. We do not accept any form of discrimination based on, but not limited to, gender identity and expression, sexual orientation, age, ethnic or national background, skin colour, religious and philosophical diversity, neurodivergence, employment disability, health, or socioeconomic status. For questions about accessibility or support offered, we are happy to assist you at this email address.

Détails de l'offre

Titre
Postdoctoral researcher to develop antisense therapies for familial Alzheimer’s
Employeur
Localisation
Oude Markt 13 Louvain, Belgique
Publié
2024-10-30
Date limite d'inscription
2024-11-29 23:59 (Europe/Brussels)
2024-11-29 23:59 (CET)
Type de poste
Enregistrer le travail

Plus d'offres de cet employeur

Affichage des offres d'emploi en Anglais, Suédois, Finnois Modifier les paramètres

A propos de l'employeur

KU Leuven is an autonomous university. It was founded in 1425. It was born of and has grown within the Catholic tradition.

Visitez la page de l'employeur